BioLife Solutions, Inc.BLFSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P21
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | -4.37% |
| 2024 | -57.91% |
| 2023 | 27.02% |
| 2022 | 25.21% |
| 2021 | 75.88% |
| 2020 | 63.11% |
| 2019 | 217.41% |
| 2018 | 8.80% |
| 2017 | -41.20% |
| 2016 | 47.16% |